Autoimmune hemolytic anemia: causes and consequences

References

• Petz LD, Garratty G. Immune Hemolytic Anemias. 2nd ed. Philadelphia: Churchill Livingstone; 2004.
   Google Scholar
• Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first international consensus meeting. Blood Rev. 2020May; 41:100648. https://doi.org/10.1016/j.blre.2019.100648. Epub 2019 Dec 5. PMID: 31839434
   PubMed Web of Science ®Google Scholar
• Barcellini W, Giannotta J, Fattizzo B. Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic procedures. Expert Rev Hematol. 2020Jun;13(6):585–597. Epub 2020 Apr 29. PMID: 32274943.
   PubMed Web of Science ®Google Scholar
• Berentsen S, Barcellini W. Autoimmune hemolytic anemias. N Engl J Med. 2021 Oct 7;385(15):1407–1419. PMID: 34614331.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Fattizzo B. The changing landscape of autoimmune hemolytic anemia. Front Immunol. 2020 Jun 3;11:946. https://doi.org/10.3389/fimmu.2020.00946. PMID: 32655543; PMCID: PMC7325906.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Zaninoni A, Giannotta JA, et al. New insights in autoimmune hemolytic anemia: from pathogenesis to therapy stage 1. J Clin Med. 2020 Nov 27;9(12):3859. PMID: 33261023; PMCID: PMC7759854.
   Google Scholar
• Fattizzo B, Barcellini W. Autoimmune cytopenias in chronic lymphocytic leukemia: focus on molecular aspects. Front Oncol. 2020 Jan 10;9:1435. DOI:https://doi.org/10.3389/fonc.2019.01435. PMID: 31998632; PMCID: PMC6967408.
   Google Scholar
• Abbas AK, Lichtman AH, Pillai S. Cellular and molecular immunology. 7th ed. Philadelphia: Saunders; 2012.
   Google Scholar
• Barcellini W, Clerici G, Montesano R, et al. In vitro quantification of anti-red blood cell antibody production in idiopathic autoimmune haemolytic anaemia: effect of mitogen and cytokine stimulation. Br J Haematol. 2000;111(2):452–460.
   PubMedGoogle Scholar
• Toriani-Terenzi C, Fagiolo E. IL-10 and the cytokine network in the pathogenesis of human autoimmune hemolytic anemia. Ann N Y Acad Sci. 2005;1051(1):29–44.
   PubMedGoogle Scholar
• Xu L, Zhang T, Liu Z, et al. Critical role of Th17 cells in development of autoimmune hemolytic anemia. Exp Hematol. 2012;40(12):994–1004.
   PubMedGoogle Scholar
• Gallagher MT, Branch DR, Mison A, et al. Evaluation of reticuloendothelial function in autoimmune hemolytic anemia using an in vitro assay of monocyte-macrophage interaction with erythrocytes. Exp Hematol. 1983Jan; 111: 82–89 PMID: 6832239.
   PubMedGoogle Scholar
• Berentsen S. Role of complement in autoimmune hemolytic anemia. Transfus Med Hemother. 2015Sep;42(5):303–310. Epub 2015 Sep 7. PMID: 26696798; PMCID: PMC4678321.
   PubMed Web of Science ®Google Scholar
• Conley CL, Lippman SM, Ness PM, et al. Autoimmune hemolytic anemia with reticulocytopenia and erythroid marrow. N Engl J Med. 1982 Feb 4;306(5):281–286. PMID: 7054700.
   PubMedGoogle Scholar
• Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients. Blood. 2014 Nov 6;124(19):2930–2936. Epub 2014 Sep 16. PMID: 25232059.
   PubMedGoogle Scholar
• Fattizzo B, Giannotta JA, Serpenti F, et al. Difficult cases of autoimmune hemolytic anemia: a challenge for the internal medicine specialist. J Clin Med. 2020 Nov 27;9(12):3858. PMID: 33261016; PMCID: PMC7760866.
   Google Scholar
• Berentsen S, Barcellini W, D’Sa S, et al., Cold agglutinin disease revisited: a multinational, observational study of 232 patients. Blood. 136(4): 480–488. 2020.
   PubMed Web of Science ®Google Scholar
• Randen U, Trøen G, Tierens A, et al. Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica. 2014;99(3):497–504.
   PubMed Web of Science ®Google Scholar
• Małecka A, Delabie J, stlie I, et al. Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18. Blood Adv. 2020;4(6):993–996.
   PubMedGoogle Scholar
• Shulman IA, Branch DR, Nelson JM, et al. Autoimmune hemolytic anemia with both cold and warm autoantibodies. JAMA. 1985 Mar 22-29;253(12):1746–1748. PMID: 3974053.
   PubMedGoogle Scholar
• Sokol RJ, Booker DJ, Stamps R, et al., Direct coombs test-negative autoimmune hemolytic anemia and low-affinity IgG class antibodies. Immunohematology. 1997;13(4):115–118.
   PubMedGoogle Scholar
• Branch DR, Petz LD. Detecting alloantibodies in patients with autoantibodies. Transfusion. 1999 Jan;39:6–10. PMID: 9920160
   PubMed Web of Science ®Google Scholar
• Hill QA, Stamps R, Massey E, et al., Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia. Br J Haematol. 2017;177(2):208–220.
   PubMed Web of Science ®Google Scholar
• Azizi G, Tavakol M, Rafiemanesh H, et al. Autoimmunity in a cohort of 471 patients with primary antibody deficiencies. Expert Rev Clin Immunol. 2017;13(11):1099–1106.
   PubMed Web of Science ®Google Scholar
• Abdel-Khalik A, Paton L, White AG, et al. Human leucocyte antigens A, B, C, and DRW in idiopathic “warm” autoimmune haemolytic anaemia. Br Med J. 1980;280(6216):760–761.
   PubMedGoogle Scholar
• Wang-Rodriguez J, Rearden A. Reduced frequency of HLA-DQ6 in individuals with a positive direct antiglobulin test. Transfusion. 1996;36(11–12):979–984.
   PubMed Web of Science ®Google Scholar
• Silberstein LE, Jefferies LC, Goldman J, et al. Variable region gene analysis of pathologic human autoantibodies to the related i and I red blood cell antigens. Blood. 1991;78(9):2372–2386.
   PubMed Web of Science ®Google Scholar
• Potter KN, Hobby P, Klijn S, et al. Evidence for involvement of a hydrophobic patch in framework region 1 of human V4-34-encoded Igs in recognition of the red blood cell I antigen. J Immunol. 2002;169(7):3777–3782.
   PubMed Web of Science ®Google Scholar
• Jefferies LC, Carchidi CM, Silberstein LE. Naturally occurring anti-i/I cold agglutinins may be encoded by different VH3 genes as well as the VH4.21 gene segment. J Clin Invest. 1993;92(6):2821–2833.
   PubMed Web of Science ®Google Scholar
• Malecka A, Trøen G, Tierens A, et al. Immunoglobulin heavy and light chain gene features are correlated with primary cold agglutinin disease onset and activity. Haematologica. 2016;101(9):e361–4.
   PubMed Web of Science ®Google Scholar
• Pavkovic M, Georgievski B, Cevreska L, et al. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders. Am J Hematol. 2003;72(2):14714–14719.
   Web of Science ®Google Scholar
• D’Abronzo LS, Barros MM, Bordin JO, et al. Analysis of polymorphisms of TNF-a, LT-a, IL-10, IL-12 and CTLA-4 in patients with warm autoimmune haemolytic anaemia. Int J Lab Hematol. 2012;34(4):356–361.
   PubMed Web of Science ®Google Scholar
• Hadjadj J, Aladjidi N, Fernandes H, et al., members of the French reference center for pediatric autoimmune cytopenia (CEREVANCE). Pediatric Evans syndrome is associated with a high frequency of potentially damaging variants in immune genes. Blood. 2019;134(1):9–21.
   PubMed Web of Science ®Google Scholar
• Malecka A, Trøen G, Tierens A, et al. Frequent somatic mutations of KMT 2D (MLL 2) and CARD 11 genes in primary cold agglutinin disease. Br J Haematol. 2018;183(5):838–842.
   PubMed Web of Science ®Google Scholar
• Feuille EJ, Anooshiravani N, Sullivan KE, et al. Autoimmune cytopenias and associated conditions in CVID: a report from the USIDNET registry. J Clin Immunol. 2018;38(1):28–34.
   PubMed Web of Science ®Google Scholar
• Odineal DD, Gershwin ME. The epidemiology and clinical manifestations of autoimmunity in selective IgA deficiency. Clin Rev Allergy Immunol. 2019;58(1):107–133.
   Google Scholar
• Oliveira JB. The expanding spectrum of the autoimmune lymphoproliferative syndromes. Curr Opin Pediatr. 2013;25(6):722–729.
   PubMed Web of Science ®Google Scholar
• Motta I, Giannotta J, Ferraresi M, et al. Autoimmune hemolytic anemia as a complication of congenital anemias. a case series and review of the literature. J Clin Med. 2021 Aug 2;10(15):3439. PMID: 34362222; PMCID: PMC8347040.
   PubMedGoogle Scholar
• Zaninoni A, Vercellati C, Imperiali FG, et al. Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis. Transfusion. 2015;55(12):2930–2938.
   PubMed Web of Science ®Google Scholar
• Gormezano NW, Kern D, Pereira OL, et al. Autoimmune hemolytic anemia in systemic lupus erythematosus at diagnosis: differences between pediatric and adult patients. Lupus. 2017;26(4):426–430.
   PubMed Web of Science ®Google Scholar
• Nenova IS, Valcheva MY, Beleva EA, et al. Autoimmune phenomena in patients with solid tumors. Folia Med (Plovdiv). 2016;58(3):195–199.
   PubMedGoogle Scholar
• Sokol RJ, Booker DJ, Stamps R. Erythrocyte autoantibodies, autoimmune haemolysis, and carcinoma. J Clin Pathol. 1994 Apr;47(4):340–343. PMID: 8027372; PMCID: PMC501938.
   PubMed Web of Science ®Google Scholar
• Kitao A, Kawamoto S, Kurata K, et al. Band 3 ectopic expression in colorectal cancer induces an increase in erythrocyte membrane-bound IgG and may cause immune-related anemia. Int J Hematol. 2020 May;111(5):657–666. Epub 2020 Jan 30. PMID: 31997080
   PubMedGoogle Scholar
• Crickx E, Poullot E, Moulis G, et al. Clinical spectrum, evolution, and management of autoimmune cytopenias associated with angioimmunoblastic T-cell lymphoma. Eur J Haematol. 2019;103(1):35–42.
   PubMed Web of Science ®Google Scholar
• Dasanu CA, Bockorny B, Grabska J, et al. Prevalence and pattern of autoimmune conditions in patients with marginal zone lymphoma: a single institution experience. Conn Med. 2015;79(4):197–200.
   PubMedGoogle Scholar
• Barcellini W, Montesano R, Clerici G, et al. In vitro production of anti-RBC antibodies and cytokines in chronic lymphocytic leukemia. Am J Hematol. 2002 Nov;713:177–183. PMID: 12410572.
   PubMed Web of Science ®Google Scholar
• Zaninoni A, Imperiali FG, Cattaneo A, et al. Detection of erythroblast antibodies in mitogen-stimulated bone marrow cultures from patients with myelodysplastic syndromes. Transfusion. 2016;56(8):2037–2041.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Iurlo A, Radice T, et al. Increased prevalence of autoimmune phenomena in myelofibrosis: relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns. Leuk Res. 2013;37(11):1509–1515.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Giannotta JA, Fattizzo B. Autoimmune complications in hematologic neoplasms. Cancers (Basel). 2021 Mar 26;13(7):1532. PMID: 33810369; PMCID: PMC8037071.
   PubMedGoogle Scholar
• Ramos-Casals M, García-Carrasco M, López-Medrano F, et al. Severe autoimmune cytopenias in treatment-naive hepatitis C virus infection: clinical description of 35 cases. Medicine (Baltimore). 2003;82(2):87–96.
   PubMed Web of Science ®Google Scholar
• Chiao EY, Engels EA, Kramer JR, et al. Risk of immune thrombocytopenic purpura and autoimmune hemolytic anemia among 120 908 US veterans with hepatitis C virus infection. Arch Intern Med. 2009;169(4):357–363.
   PubMedGoogle Scholar
• Stein B, DeCredico N, Hillman L. Evaluation of the Direct Antiglobulin Test (DAT) in the setting of mycoplasma pneumoniae Infection. JAMA. 2018;319(13):1377–1378.
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Goldacre R, Skingsley A, et al. Associations between selected immune-mediated diseases and tuberculosis: record-linkage studies. BMC Med. 2013;11(1):97.
   PubMedGoogle Scholar
• Fattizzo B, Cavallaro F, Folino F, et al. Recent insights into the role of the microbiome in malignant and benign hematologic diseases. Crit Rev Oncol Hematol. 2021Apr; 160: 103289. Epub 2021 Mar 2. PMID: 33667659
   PubMedGoogle Scholar
• Garratty G. Drug-induced immune hemolytic anemia. Hematology Am Soc Hematol Educ Program. 2009;2009(1):73–79. PMID: 20008184.
   Google Scholar
• Habibi B. Drug induced red blood cell autoantibodies co-developed with drug specific antibodies causing haemolytic anaemias. Br J Haematol. 1985Sep;61(1):139–143. PMID: 2864949.
   PubMedGoogle Scholar
• Mueller-Eckhardt C, Salama A. Drug-induced immune cytopenias: a unifying pathogenetic concept with special emphasis on the role of drug metabolites. Transfus Med Rev. 1990;4(1):69–77.
   PubMedGoogle Scholar
• Fischer K, Bahlo J, Fink AM, et al. Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial. Blood. 2016;127(2):208–215.
   PubMed Web of Science ®Google Scholar
• Autore F, Pasquale R, Innocenti I, et al. Autoimmune hemolytic anemia in chronic lymphocytic leukemia: a comprehensive review. Cancers (Basel). 2021 Nov 19;13(22):5804. PMID: 34830959; PMCID: PMC8616265.
   PubMedGoogle Scholar
• Moreno C. Autoimmune cytopenia and CLL ride together. Blood. 2021 Jun 24;137(25):3464–3465. PMID: 34165542.
   PubMedGoogle Scholar
• Vitale C, Salvetti C, Griggio V, et al. Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs. Blood. 2021 Jun 24;137(25):3507–3517. PMID: 33651883.
   PubMedGoogle Scholar
• Tanios GE, Doley PB, Munker R. Autoimmune hemolytic anemia associated with the use of immune checkpoint inhibitors for cancer: 68 cases from the food and drug administration database and review. Eur J Haematol. 2019;102(2):157–162.
   PubMed Web of Science ®Google Scholar
• Leaf RK, Ferreri C, Rangachari D, et al. Clinical and laboratory features of autoimmune hemolytic anemia associated with immune checkpoint inhibitors. Am J Hematol. 2019;94(5):563–574.
   PubMed Web of Science ®Google Scholar
• Schubert ML, Schmitt M, Wang L, et al. Side-effect management of chimeric antigen receptor (CAR) T-cell therapy. Ann Oncol. 2021;32(1):34–48.
   PubMed Web of Science ®Google Scholar
• Hows J, Beddow K, Gordon-Smith E, et al. Donor-derived red blood cell antibodies and immune hemolysis after allogeneic bone marrow transplantation. Blood. 1986Jan; 67(1): 177–181. PMID: 3079641.
   PubMedGoogle Scholar
• Skeate R, Singh C, Cooley S, et al. Hemolytic anemia due to passenger lymphocyte syndrome in solid malignancy patients treated with allogeneic natural killer cell products. Transfusion. 2013;53(2):419–423.
   PubMed Web of Science ®Google Scholar
• Barcellini W, Fattizzo B, Zaninoni A. Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives. J Blood Med. 2019;10:265–278.
   PubMed Web of Science ®Google Scholar
• González-Vicent M, Sanz J, Fuster JL, et al. Autoimmune hemolytic anemia (AIHA) following allogeneic hematopoietic stem cell transplantation (HSCT): a retrospective analysis and a proposal of treatment on behalf of the Grupo Español De Trasplante De Medula Osea En Niños (GETMON) and the Grupo Español de Trasplante Hematopoyetico (GETH). Transfus Med Rev. 2018;S0887-7963:30164–30165.
   Google Scholar
• Kruizinga MD, VT MJD, Bekker V, et al., Risk factors, treatment, and immune dysregulation in autoimmune cytopenia after allogeneic hematopoietic stem cell transplantation in pediatric patients. Biol Blood Marrow Transplant. 24(4): 772–778. 2018.
   PubMed Web of Science ®Google Scholar
• Dube SR, Fairweather D, Pearson WS, et al. Cumulative childhood stress and autoimmune diseases in adults. Psychosom Med. 2009Feb;712:243–250. Epub 2009 Feb 2. PMID: 19188532; PMCID: PMC3318917
   PubMed Web of Science ®Google Scholar
• Felitti VJ, Anda RF, Nordenberg D, et al. The relationship of adult health status to childhood abuse and household dysfunction. Am J Prev Med. 1998;14(4):245–258.
   PubMed Web of Science ®Google Scholar
• Danese A, Pariante CM, Caspi A, et al. Childhood maltreatment predicts adult inflammation in a life-course study. Proc Nat Acad Sci. 2007;104(4):1319–1324.
   PubMed Web of Science ®Google Scholar
• Zhao CN, Xu Z, Wu GC, et al. Emerging role of air pollution in autoimmune diseases. Autoimmun Rev. 2019Jun;186:607–614. Epub 2019 Apr 5. PMID: 30959217.
   PubMed Web of Science ®Google Scholar
• Farhat SC, Silva CA, Orione MA, et al. Air pollution in autoimmune rheumatic diseases: a review. Autoimmun Rev. 2011Nov;111:14–21. Epub 2011 Jul 6. PMID: 21763467.
   PubMedGoogle Scholar
• Honda T, Pun VC, Manjourides J, et al. Anemia prevalence and hemoglobin levels are associated with long-term exposure to air pollution in an older population. Environ Int. 2017 Apr;101:125–132. Epub 2017 Jan 31. PMID: 28153527; PMCID: PMC5361751.
   PubMedGoogle Scholar
• Barcellini W, Fattizzo B. How I treat warm autoimmune hemolytic anemia. Blood. 2021;137(10):1283–1294.
   PubMed Web of Science ®Google Scholar
• Michel M, Terriou L, Roudot-Thoraval F, et al., A randomized and double-blind controlled trial evaluating the safety and efficacy of rituximab for warm autoimmune hemolytic anemia in adults (the RAIHA study). Am J Hematol. 92(1): 23–27. 2017.
   PubMed Web of Science ®Google Scholar
• Murakhovskaya I. Rituximab use in warm and cold autoimmune hemolytic anemia. J Clin Med. 2020;9(12):4034.
   Google Scholar
• Patel NY, Chilsen AM, Mathiason MA, et al. Outcomes and complications after splenectomy for hematologic disorders. Am J Surg. 2012;204(6):1014–1019.
   PubMed Web of Science ®Google Scholar
• Berentsen S. How I treat cold agglutinin disease. Blood. 2021;137(10):1295–1303.
   PubMed Web of Science ®Google Scholar
• Berentsen S, Randen U, Oksman M, et al. Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial. Blood. 2017 Jul 27;130(4):537–541. Epub 2017 May 22. PMID: 28533306.
   PubMedGoogle Scholar
• Pasquale R, Giannotta JA, Barcellini W, et al. Bortezomib in autoimmune hemolytic anemia and beyond. Ther Adv Hematol. 2021 Nov 12;12:20406207211046428. PMID: 34795889; PMCID: PMC8593301.
   Google Scholar
• Jalink M, Berentsen S, Castillo JJ, et al. Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome. Blood. 2021 Nov 18;138(20):2002–2005. PMID: 34293088.
   PubMedGoogle Scholar
• Lau-Braunhut SA, Stone H, Collins G, et al. Paroxysmal cold hemoglobinuria successfully treated with complement inhibition. Blood Adv. 2019 Nov 26;3(22):3575–3578. PMID: 31738828; PMCID: PMC6880888.
   PubMedGoogle Scholar
• Fattizzo B, Michel M, Zaninoni A, et al. Efficacy of recombinant erythropoietin in autoimmune hemolytic anemia: a multicenter international study. Haematologica. 2021 Feb 1;106(2):622–625. PMID: 32354865; PMCID: PMC7849557.
   PubMedGoogle Scholar
• Röth A, Barcellini W, D’Sa S, et al. Sutimlimab in cold agglutinin disease. N Engl J Med. 2021 Apr 8;384(14):1323–1334. PMID: 33826820.
   PubMedGoogle Scholar
• Barcellini W, Zaninoni A, Fattizzo B, et al. Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from eight Italian reference centers. Am J Hematol. 2018Sep;939:E243–6. Epub 2018 Aug 25. PMID: 29981267
   PubMed Web of Science ®Google Scholar
• Fattizzo B, Michel M, Giannotta JA, et al. Evans syndrome in adults: an observational multicenter study. Blood Adv. 2021 Dec 28;5(24):5468–5478. PMID: 34592758; PMCID: PMC8714709.
   PubMedGoogle Scholar
• Audia S, Bach B, Samson M, et al. Venous thromboembolic events during warm autoimmune hemolytic anemia. PLoS One. 2018;13(11):e0207218.
   PubMed Web of Science ®Google Scholar
• Broome CM, Cunningham JM, Mullins M, et al. Increased risk of thrombotic events in cold agglutinin disease: a 10-year retrospective analysis. Res Pract Thromb Haemost. 2020 Apr 9;4(4):628–635. PMID: 32548562; PMCID: PMC7292660.
   PubMedGoogle Scholar
• Fattizzo B, Bortolotti M, Giannotta JA, et al. Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia. J Thromb Haemost. 2022 May 12; Epub ahead of print. PMID: 35555857.
   Google Scholar
• Barcellini W, Zaninoni A, Giannotta JA, et al. Circulating extracellular vesicles and cytokines in congenital and acquired hemolytic anemias. Am J Hematol. 2021 Apr 1;96(4):E129–32. Epub 2021 Feb 9. PMID: 33491786.
   PubMedGoogle Scholar
• Samuelson Bannow BT, Lee A, Khorana AA, et al. Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH. J Thromb Haemost. 2018;16(6):1246–1249.
   PubMed Web of Science ®Google Scholar
• Giannotta JA, Fattizzo B, Barcellini W. Infectious complications in a cohort of autoimmune hemolytic anemia patients. Annual meeting of the European Hematology Association. Hemasphere 2020. Abstract n. PB2401.
   Google Scholar
• Giannotta JA, Fattizzo B, Cavallaro F, et al. Infectious complications in autoimmune hemolytic anemia. J Clin Med. 2021 Jan 5;10(1):164. PMID: 33466516; PMCID: PMC7796467.
   Google Scholar
• Fattizzo B, Zaninoni A, Giannotta JA, et al. Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review. Autoimmun Rev. 2016Jul;157:770–775. Epub 2016 Mar 14. PMID: 26988993
   PubMedGoogle Scholar
• Barcellini W, Fattizzo B, Zaninoni A, et al. Clinical evolution of autoimmune cytopenias to idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and bone marrow failure syndromes. Am J Hematol. 2017;92(3):E26–9.
   PubMed Web of Science ®Google Scholar
• Fattizzo B, Giannotta J, Zaninoni A, et al. Small paroxysmal nocturnal hemoglobinuria clones in autoimmune hemolytic anemia: clinical implications and different cytokine patterns in positive and negative patients. Front Immunol. 2020 Jun 4;11:1006. PMID: 32582157; PMCID: PMC7287021.
   PubMedGoogle Scholar
• Barcellini W, Fattizzo B, Cortelezzi A. Autoimmune hemolytic anemia, autoimmune neutropenia and aplastic anemia in the elderly. Eur J Intern Med. 2018;58:77–83.
   PubMed Web of Science ®Google Scholar
• Rattarittamrong E, Eiamprapai P, Tantiworawit A, et al. Clinical characteristics and long-term outcomes of warm-type autoimmune hemolytic anemia. Hematology. 2016;21(6):368–374.
   PubMed Web of Science ®Google Scholar
• Fattizzo B, Zaninoni A, Nesa F, et al. Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias. Am J Hematol. 2015;90(8):E149–51.
   PubMed Web of Science ®Google Scholar
• Lafarge A, Bertinchamp R, Pichereau C, et al., Prognosis of autoimmune hemolytic anemia in critically ill patients. Ann Hematol. 98(3): 589–594. 2019.
   PubMed Web of Science ®Google Scholar
• Hill QA, Horan M, Charlton A, et al. Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience. Br J Haematol. 2021Jan;1922:e54–7. Epub 2020 Nov 20. PMID: 33216965
   PubMedGoogle Scholar
• Fattizzo B. Evans syndrome in the SARS-CoV-2 era: “springing up like mushrooms.” Blood Transfus. 2021 Dec 1; Epub ahead of print. PMID: 34967726.
   Google Scholar
• Osti N, Ceolan J, Piccoli P, et al. Acute haemolysis by cold antibody during SARS-CoV-2 infection in a patient with Evans syndrome: a case report and literature review. Blood Transfus. 2021;20(2):168–172.
   PubMedGoogle Scholar
• Barcellini W, Giannotta JA, Fattizzo B. Are patients with autoimmune cytopenias at higher risk of COVID-19 pneumonia? The experience of a reference center in Northern Italy and review of the literature. Front Immunol. 2021;11:609198.
   PubMedGoogle Scholar
• Haberman R, Axelrad J, Chen A, et al. Covid-19 in immune-mediated inflammatory diseases. Case series from New York. N Engl J Med. 2020;383(1):85–88.
   PubMed Web of Science ®Google Scholar
• Angileri F, Légaré S, Marino Gammazza A, et al. Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19? Br J Haematol. 2020;190(2):e92–3.
   PubMed Web of Science ®Google Scholar
• Chauhan AJ, Wiffen LJ, Brown TP. COVID-19: a collision of complement, coagulation and inflammatory pathways. J Thromb Haemost. 2020;18(9):2110–2117.
   PubMed Web of Science ®Google Scholar
• Kubánková M, Hohberger B, Hoffmanns J, et al. Physical phenotype of blood cells is altered in COVID-19. bioRxiv. 2021;120:2838–2847.
   Google Scholar
• Jacobs J, Eichbaum Q. COVID −19 associated with severe autoimmune hemolytic anemia. Transfusion. 2021;61(2):635–640.
   PubMed Web of Science ®Google Scholar
• Avouac J, Drumez E, Hachulla E, et al. COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study. Lancet Rheumatol. 2021;10:1016/S2665-9913(21)00059–X. [Epub ahead of print.
   Google Scholar
• Fattizzo B. Evans syndrome and infections: a dangerous cocktail to manage with caution. Blood Transfus. 2021;19(1):5–8.
   PubMedGoogle Scholar
• Ehmsen S, Asmussen A, Jeppesen SS, et al. Antibody and T cell immune responses following mRNA COVID-19 vaccination in patients with cancer. Cancer Cell. 2021;39(8):1034–1036.
   PubMedGoogle Scholar
• Murdych TM. A case of severe autoimmune hemolytic anemia after a receipt of a first dose of SARS-CoV-2 vaccine. Int J Lab Hematol. 2021;44(1):e10–e12. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Brito S, Ferreira N, Mateus S, et al. A case of autoimmune hemolytic anemia following COVID-19 messenger ribonucleic acid vaccination. Cureus. 2021;13(5):e15035.
   PubMedGoogle Scholar
• Pérez-Lamas L, Moreno-Jiménez G, Tenorio-Núñez MC, et al. Hemolytic crisis due to Covid-19 vaccination in a woman with cold agglutinin disease. Am J Hematol. 2021;96(8):e288–91.
   PubMedGoogle Scholar
• Fattizzo B, Giannotta JA, Cecchi N, et al. SARS-CoV −2 vaccination in patients with autoimmune cytopenias: the experience of a reference center. Am J Hematol. 2021;96(11):e413–6.
   PubMed Web of Science ®Google Scholar
• Simpson CR, Shi T, Vasileiou E, et al. First-dose ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic and hemorrhagic events in Scotland. Nat Med. 2021;27(7):1290–1297.
   PubMed Web of Science ®Google Scholar
• Welsh KJ, Baumblatt J, Chege W, et al. Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2021;39(25):3329–3332.
   PubMed Web of Science ®Google Scholar